vazkepa
amarin pharmaceuticals ireland limited - icosapent ethyl - dyslipidémia - Činidlá modifikujúce lipidy - indicated to reduce cardiovascular risk as an adjunct to statin therapy.
Unjoni Ewropea -
Slovakk -
EMA (European Medicines Agency)